Parapsoriasishttps://en.wikipedia.org/wiki/Parapsoriasis
Parapsoriasis refertur ad unam ex grege morborum cutis quae, praecipue, proprietatem similitudinis cum psoriasis (rubri, squamarum laesiones) habet. Parapsoriasis est rara dermatitis lymphoproliferativa cutis, quae maxime in adultis mediae aetatis occurrit, duarum partium trium masculini sunt.

Cancer cutis ex parapsoriasis provenire potest. Exempli gratia, potest in lymphoma cutaneum T‑cellulum evolvere.

○ Diagnosis et curatio
Examen sanguinis ad syphilitidem excludendam probatur.
Biopsia ad detectionem lymphomatum cutaneorum praebenda est.

☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
      References Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review 35426607 
      NIH
      Parapsoriasis is an uncommon inflammatory skin disease characterized by chronic patches that may be resistant to therapy. It was primarily introduced and classified 120 years ago, and the original classification incorporated parapsoriasis and pityriasis lichenoides under the umbrella term parapsoriasis. After a major change in classification, parapsoriasis now exclusively refers to small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP). However, debates still frequently occur regarding various nomenclatures and classifications used by different authors. Moreover, parapsoriasis may progress to overt cutaneous lymphoma, most commonly mycosis fungoides (MF), and it is very difficult to distinguish these two conditions despite modern histologic and molecular testing techniques.
       Histopathologic Evaluation of Parapsoriasis from the Perspective of NB-UVB/PUVA Therapy on the Outcome and Recurrence of the Disease 33911303 
      NIH
      Parapsoriasis, presented as an early stage of cutaneous T-cell lymphoma, is mostly treated with psoralen and ultraviolet A (PUVA) therapy and narrowband ultraviolet B (NB-UVB) phototherapy.